Co-Authors
This is a "connection" page, showing publications co-authored by Bodil Rasmussen and Anders Perner.
Connection Strength
1.763
-
Low-dose hydrocortisone in patients with COVID-19 and severe hypoxia: The COVID STEROID randomised, placebo-controlled trial. Acta Anaesthesiol Scand. 2021 11; 65(10):1421-1430.
Score: 0.242
-
Oxygenation targets in ICU patients with COVID-19: A post hoc subgroup analysis of the HOT-ICU trial. Acta Anaesthesiol Scand. 2022 01; 66(1):76-84.
Score: 0.242
-
Higher vs lower doses of dexamethasone in patients with COVID-19 and severe hypoxia (COVID STEROID 2) trial: Protocol and statistical analysis plan. Acta Anaesthesiol Scand. 2021 Jul; 65(6):834-845.
Score: 0.233
-
Higher vs Lower Doses of Dexamethasone in Patients with COVID-19 and Severe Hypoxia (COVID STEROID 2) trial: Protocol for a secondary Bayesian analysis. Acta Anaesthesiol Scand. 2021 05; 65(5):702-710.
Score: 0.233
-
Characteristics, interventions, and longer term outcomes of COVID-19 ICU patients in Denmark-A nationwide, observational study. Acta Anaesthesiol Scand. 2021 01; 65(1):68-75.
Score: 0.227
-
Low-dose hydrocortisone in patients with COVID-19 and severe hypoxia (COVID STEROID) trial-Protocol and statistical analysis plan. Acta Anaesthesiol Scand. 2020 10; 64(9):1365-1375.
Score: 0.224
-
Oxygenation targets in acutely ill patients: still a matter of debate. Lancet. 2018 12 08; 392(10163):2436-2437.
Score: 0.200
-
Handling oxygenation targets in ICU patients with COVID-19-Protocol and statistical analysis plan in the HOT-COVID trial. Acta Anaesthesiol Scand. 2021 11; 65(10):1497-1504.
Score: 0.060
-
Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Patients With Septic Shock: The SEPSIS-ACT Randomized Clinical Trial. JAMA. 2019 Oct 15; 322(15):1476-1485.
Score: 0.053
-
Pantoprazole in Patients at Risk for Gastrointestinal Bleeding in the ICU. N Engl J Med. 2018 12 06; 379(23):2199-2208.
Score: 0.049